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Abstract
Autosomal dominant (Thomsen) and recessive (Becker) congenital myotonia are two different non
dystrophic disorders, due to allelic mutations of the muscle chloride channel gene, located on
chromosome 7q35. More than two thirds of the muscle chloride channel gene mutations occur
independently in unique families and cause the recessive form of the disease. Becker disease is
more common and severe than Thomsen disease. Here, we report on the clinical and molecular
data of the first patient with maternal uniparental disomy for chromosome 7 and recessive
congenital myotonia. The proband is a 15-year-old male, homozygous for a missense mutation
within muscle chloride channel gene, showing few characteristic signs of the Silver Russell
Syndrome.
Introduction
Thomsen (autosomal dominant; OMIM # 160800) and
Becker (autosomal recessive; OMIM # 255700) myotonia
are characterised by muscle stiffness and myotonia, which
is based on an electrical instability of the muscle fiber
membrane. The diseases differ clinically by age at onset, by
spreading of the symptom myotonia, and by a typical
transient muscle weakness only present in the dominant
form of the disease. The most prominent symptom of
Thomsen’s disease is muscle stiffness that starts in early
childhood, but it is, however, temporary. The dominant
form occurs with a frequency of 1:23,000 to 1:50,000
[1,2]. Both diseases are caused by mutations within the
chloride channel gene (CLCN1) gene, coding for the
skeletal muscle voltage-dependent Chloride channel and
located on 7q35 [3,4]. Up to date 80 different mutations
have been reported, the most frequent ones ranging about
0.7% in myotonic patients. Chloride channel mutations
are mainly loss-of-function mutations that reduce the
stabilizing chloride conductance. Consequently, most of
the chloride channel mutations are recessive traits. The few
dominant or semidominant mutations act through
dominant negative heterodimerization with subunits
encoded by the wild-type allele [5,6].
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genetically heterogeneous disease characterised by intra-
uterine growth retardation, postnatal growth delay, a
typical facial appearance with a small triangular face,
frontal bossing, thin lips with downturned corners,
micrognathia and a variable degree of body asymmetry.
Most cases of SRS are sporadic and about 10% of affected
individuals shown a maternal disomy for chromosome 7.
Cognitive development is variable, with many individuals
demonstrating developmental and learning disabilities.
Here we report the first case of Becker recessive myotonia
resulting from a maternal isodisomy of the entire
chromosome 7.
Case Presentation
The proband, a Caucasian 15-year-old male, is the only
child of healthy, non-consaguineous parents. Family
history was unremarkable and pregnancy was uneventful.
He was born at the 36
th week of pregnancy, with a weight
of 2120 g (10
th–25
th centile) and a length at 44 cm (10
th
centile).
He has never crawled on four limbs but achieved
independent walking at the age of 11 months, showing a
wide-based, awkward gait with stiffness inlower limbs and
difficulty to begin ambulation after aprolonged rest. Inthe
first two years of life, he suffered from two febrile seizure
episodes (the EEG findings were normal) and presented
language delay (he spoke 10–15 words at 4 years). Since
then he started language therapy with appreciable results.
A neurocognitive assessment was performed at 4 years and
4 months of age showing a normal range of intelligence
(median IQ score on the WPPSI was 95). He attended
school with special education needs because of difficulties
in reading and writing. At 5 years, extensive investigations
were performed: cerebral MRI, echocardiogram, ophthal-
mological examination and audiometric test were all
normal. The electromyography (EMG) revealed the pre-
sence of typical myotonic runs (EMG performed in his
parents was normal). The serum Creatine Phosphokinase
(CPK) was elevated above the normal range (382 U/L,
with normal levels being below 270 U/L) in only one
occasion, at the age of two years, and reached normal
values in the two following measurements. A chest X-ray
revealed the presence of dorso-lumbar scoliosis. The
thyroid hormonal levels were normal. Muscular biopsy
at 5 years revealed mildmyopathic change andtypeI fibers
hypotrophy. The FRAXA molecular analysis was negative.
He became toiled trained at the expected age. At the age of
7 years he underwent treatment with dyphenilhydantoine
for 12 months (the mean dosage was 100 mg/day) but no
relief of the myotonia was noticed. Moreover at 10 years a
surgical correction for left clubfoot was performed. On
careful clinical examination at 15 years, the patient
weighted 75.5 Kg (>97
th centile), his height was 163 cm
(25
th centile) and his head circumference was 59 cm
(+2.7 SD).
He presented only few mild cranio-facial dysmorphisms
suggestive for SRS: a relative macrocephaly, a small face
with a broad forehead, deep set eyes and micrognathia.
These clinical findings were more relevant during the first
years of life (Figure 1A–C). The palate was high arched and
no limb asymmetry was observed. He referred excessive
sweating.
During neurological examination, muscle hypertrophy at
lower limbs was noticed and myotonia in all four limbs
was evident. The boy showed independent walking with
lower limb stiffness and weakness; the muscle strength was
normal, the Gower’s sign was negative; deep tendon
reflexes were weak in the upper limbs and brisk in the
lower limbs with ankle increased tone.
Molecular Analysis
Proband’s DNA was screened for CLCN1 mutations
together with his non-consanguineous parents, after
obtaining signed informed consent. Genomic DNA was
extracted from the whole blood of the patient and his
parents using the BioRobot EZ1 automated purification
(QIAGEN). Sequence analysis of muscle chloride channel
Figure 1.
(A) The patient at the age of 2 years. The craniofacial
dysmorphisms are more relevant at this age. (B) and (C) The
patient at the age of 15 years. Improvement in the facial gestalt
is evident.
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zygosity for a G to A transition (c.1063G>A), leading to p.
G355R mutation, previously characterised as caused by
another nucleotide modification (Figure 2). The mutated
allele was segregating only from the mother (heterozygous
for the p.G355R mutation) while no mutated allele was
detected in the father. Non paternity was immediately
excluded using a panel 15 highly polymorphic markers
and one marker for amelogenin (AmpFlSTR identifiler).
Furthermore, chromosome 7 markers showed an anom-
alous segregation within the family suggesting an unipar-
ental transmission. A set of nine additional polymorphic
markers spanning the entire chromosome 7 (D7S641,
D7S691, D7S2427, D7S1870, D7S2459, D7S2513,
D7S661, D7S636 and D7S2423) were therefore analysed
(Figure 2). Amplifications were analysed on automated
sequencer (ABI 3130 Applied Biosystem). PCR were
performed in 15 µL reactions containing 100 ng DNA,
1,5 mM MgCl2, 150 uM of each dNTPs, 150 mM Buffer,
0.15 U Ampli Taq Gold. Thermocycling was performed on
a 9700 Applied Biosystems, using the following condi-
tions: an initial denaturation at 95°C for 12 min, followed
by 10 cycles each of 94°C for 15 sec, annealing at 55°C for
15 sec and an extension at 72°C for 30 sec, followed by 20
cycles each of 89°C for 15sec, annealing at 55°C for 15sec
and an extension at 72°C for 30 sec. Finally an extension
step at 72°C for 10 min. PCR products were analysed on
ABI 3130 XL Gene Mapper (Applied Biosystems). The
results unambiguously demonstrated the presence of a
maternal isodisomy of the entire chromosome 7
(matUPD7) in the proband (Figure 2).
Discussion
UPD occurs when an individual inherits two copies of a
chromosome pair from one parent, and no copy from the
otherparent.Ourresultsdemonstratethattheprobandhas
twoentirelyidentical chromosomes7,bothinheritedfrom
the mother. This could have been due either to a disomic
maternal gamete that did not undergo recombination of
chromosome 7 during oogenesis or to a post meiotic
reduplication or non disjunction of the chromosome 7.
The first observation of UPD in humans was a maternal
UPD 7 in two individuals suffering from Cystic Fibrosis
(FC), severe growth restriction and growth hormone
deficiency, but the face was not typical of SRS [7]. Both
patients were isodisomic, and consequently homozygous
for a CFTR mutation carried by their mothers.
To date, over 49 cases of maternal UPD7 have been
reported. Within these, about 30 characterised by growth
retardation have been reported, suggesting that imprinted
growth-regulating genes reside on chromosome 7 [8]. In
fact maternal UPD7 is predominantly observed among
patients with SRS (about 10%) and disrupted genomic
imprinting is suggested as the etiological basis for the
severe growth retardation [7,8].
On the other hand, only four cases of paternal UPD7 have
been reported, all associated with recessive disorders but
compatible with normal growth. [9]. All patients had
normal pre- and postnatal growth except for one who
developed severe postnatal growth retardation, likely due
to his serious medical problems. For these reasons, it is
possible that most cases of paternal UPD are without
phenotypic effects and remain undiagnosed.
In conclusion, chromosome 7 demonstrates imprinting
with differing phenotypes for both maternal and paternal
UPD. In maternal UPD7, imprinting results in pre and
postnatal growth retardation with many of the clinical
findingsoftheSRS.InpaternalUPD7,phenotypiceffectsare
limited to autosomal recessive disorders inherited from a
heterozygous father,mainlyregarding Cystic Fibrosisdue to
the high CF carrier rate in Caucasian populations.
Figure 2.
Family pedigree with the corresponding haplotypes for
chromosome 7 and sequence analysis.
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Becker disease, caused by a maternal isodisomy of
chromosome 7. The novel mutation characterised within
CLCN1 gene alters an amino acid already reported as
modified by another nucleotide substitution, allowing us
to consider it a mutation hot spot.
The presence of maternal UPD7 in this patient is causative
of both Becker myotonia (due to the two identical copies
of the recessive disease-causing gene) and some clinical
signs characteristic of SRS (with a craniofacial phenotype
being more relevant during childhood) (Fig. 1A–C).
The SRS due to matUPD7 is supposed to be a distinctive
subgroup characterized by a milder facial phenotype and
additional specific features such as severe speech delay,
feeding difficulties excessive sweating and pre-and post-
natal growth retardation [10]. The SRS features fade as
children grow older.
The patient we have reported about, however, has never
presented development delay even though all SRS cases
due to maternal UPD 7 reported so far had significant
growth retardation.
Although UPD7 appears to be rare,our report suggests that
an appropriate genetic counselling at this respect, is
indicated within families with individuals heterozygous
for CLCN1 mutations.
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